Authors:
Redgrave, TG
Watts, GF
Martins, IJ
Barrett, PHR
Mamo, JCL
Dimmitt, SB
Marais, AD
Citation: Tg. Redgrave et al., Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test, J LIPID RES, 42(5), 2001, pp. 710-715
Authors:
Watts, GF
Barrett, PHR
Marais, AD
Dane-Stewart, CA
Martins, IJ
Dimmitt, SB
Redgrave, TG
Citation: Gf. Watts et al., Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test, ATHEROSCLER, 157(2), 2001, pp. 519-523
Citation: Gmb. Berger et Ad. Marais, Diagnosis, management and prevention of the common dyslipidaemias in SouthAfrica - Clinical guideline, 2000, S AFR MED J, 90(2), 2000, pp. 164
Authors:
Raal, FJ
Pappu, AS
Illingworth, DR
Pilcher, GJ
Marais, AD
Firth, JC
Kotze, MJ
Heinonen, TM
Black, DM
Citation: Fj. Raal et al., Inhibition of cholesterol synthesis by atorvastatin in homozygous familialhypercholesterolaemia, ATHEROSCLER, 150(2), 2000, pp. 421-428
Authors:
Scholtz, CL
Peeters, AV
Hoogendijk, CF
Thiart, R
de Villiers, JNP
Hillermann, R
Liu, JW
Marais, AD
Kotze, MJ
Citation: Cl. Scholtz et al., Mutation-59c -> t in repeat 2 of the LDL receptor promoter: reduction in transcriptional activity and possible allelic interaction in a South Africanfamily with familial hypercholesterolaemia, HUM MOL GEN, 8(11), 1999, pp. 2025-2030
Authors:
Hislop, MS
Ratanjee, BD
Soule, SG
Marais, AD
Citation: Ms. Hislop et al., Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men, EUR J ENDOC, 141(1), 1999, pp. 40-46
Authors:
Loubser, O
Marais, AD
Kotze, MJ
Godenir, N
Thiart, R
Scholtz, CL
de Villiers, JNP
Hillermann, R
Firth, JC
Weich, HFH
Maritz, F
Jones, S
van der Westhuyzen, DR
Citation: O. Loubser et al., Founder mutations in the LDL receptor gene contribute significantly to thefamilial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry, CLIN GENET, 55(5), 1999, pp. 340-345